Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03851614
Title Basket Combination Study of Inhibitors of DNA Damage Response, Angiogenesis and Programmed Death Ligand 1 in Patients With Advanced Solid Tumors (DAPPER)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University Health Network, Toronto

colorectal cancer

pancreatic adenocarcinoma



Cediranib + Durvalumab

Durvalumab + Olaparib

Age Groups: adult | senior
Covered Countries CAN

Additional content available in CKB BOOST